SCHEMBL8102673

SCHEMBL8102673

CCCCC(=O)NC1=C(c2ccccc2)c2ccccc2C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.57
HSP90AB1 P08238 4/20 0.57
TDP2 O95551 1/20 0.57
PAX8 Q06710 1/20 0.57
HKDC1 Q2TB90 1/20 0.57
TLR9 Q9NR96 1/20 0.57
SOAT1 P35610 2/20 0.56
PTPN1 P18031 1/20 0.53
ADORA1 P30542 2/20 0.51
ADORA3 P0DMS8 1/20 0.48
ALDH1A1 P00352 1/20 0.48
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPT P10636 1/20 0.47
FGFR1 P11362 2/20 0.47
FGFR2 P21802 2/20 0.47
FGFR4 P22455 2/20 0.47
FGFR3 P22607 2/20 0.47
SRC P12931 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8102319 0.92 TDP2 (0.68) HSP90AA1HSP90AB1TDP2PAX8HKDC1
SCHEMBL8102104 0.90 TDP2 (0.52) HSP90AA1HSP90AB1TDP2PAX8HKDC1
SCHEMBL8108751 0.88 TDP2 (0.56) HSP90AA1HSP90AB1TDP2PAX8HKDC1
SCHEMBL8100343 0.87 HSP90AA1 (0.61) HSP90AA1HSP90AB1TDP2PAX8HKDC1
SCHEMBL8102479 0.83 TDP2 (0.59) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8100892 0.83 TDP2 (0.59) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8665336 0.82 TDP2 (0.58) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8092553 0.81 TDP2 (0.61) HSP90AA1HSP90AB1TDP2PAX8HKDC1
SCHEMBL8092735 0.81 TDP2 (0.57) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8093107 0.81 TDP2 (0.57) TDP2PAX8HKDC1TLR9SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013674-A INDENONE AMIDE DERIVATIVES, USEFUL FOR FOR THE INHIBITION OF LEUKOCYTE ADHERENCE TO ENDOTHELIAL CELLS; USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, AS ARTHRITIS, ASTHAMA, PSORIASIS, RESPIRATORY DISTRESS SYNDROME, STROKE AND ULCER ELI LILLY AND COMPANY (US) 2000-01-11 US disclosed
EP-0882706-A1 Cell adhesion inhibitors ELI LILLY AND COMPANY (US) 1998-12-09 EP disclosed